当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第18期
编号:13423891
血液透析专用中心静脉导管封管液的研究(4)
http://www.100md.com 2019年5月7日 《医学信息》 2019年第18期
     [25]金艳鸿,尹璐.三种封管液对血滤患者中心静脉导管封管效果的比较研究[J].中国医药导报,2017,14(28):178-180.

    [26]Moore CL,Besarab A,Ajluni M,et al.Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients[J].Clin J Am Soc Nephrol,2014,9(7):1232-1239.

    [27]檀敏,翟薇.加强透析室感染控制提高患者生存质量[J].中国护理管理,2010,10(7):68-70.

    [28]Nguyen DB,Shugart A,Lines C,et al.National Healthcare Safety Network(NHSN)Dialysis Event Surveillance Report for 2014[J].Clin J Am Soc Nephrol,2017,12(7):1139-1146.

    [29]Pittiruti M,Bertoglio S,Scoppettuolo G,et al.Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters(excluding dialysis catheters):a GAVeCeLT consensus[J].J Vasc Access,2016,17(6):453-464.

    [30]Vercaigne LM,Allan DR,Armstrong SW,et al.An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections:a randomized pilot study[J].J Vasc Access,2016,17(1):55-62.

    收稿日期:2019-6-10;修回日期:2019-6-20

    編辑/杨倩, http://www.100md.com(谢华 周毅峰 甘晓庆)
上一页1 2 3 4